Luca Palmieri

7PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 08, 2025
Robotic secondary cytoreduction in recurrent ovarian cancer: a tailored approach for kidney transplant recipients.

Silvio Andrea Russo, Riccardo Oliva, Camilla Certelli

|Sep 27, 2025
Preclinical Efficacy of the Estrogen Receptor Degrader Fulvestrant in Combination with RAF/MEK Clamp Avutometinib and FAK Inhibitor in a Low-Grade Serous Ovarian Cancer Animal Model with Acquired Resistance to Chemotherapy and Aromatase Inhibitor.

Cem Demirkiran, Stefania Bellone, Victoria M Ettorre

|Aug 27, 2025
HER2/neu as a Signaling and Therapeutic Marker in Uterine Serous Carcinoma.

Victoria M Ettorre, Luca Palmieri, Valentino Clemente

|Aug 27, 2025
Preclinical Activity of Datopotamab Deruxtecan (Dato-DXd), an Antibody-Drug Conjugate Targeting TROP2, in Poorly Differentiated Endometrial Carcinomas.

Niccolò G Santin, Namrata Sethi, Stefania Bellone

|Oct 25, 2024
Robotic Rectosigmoid Resection with Totally Intracorporeal Colorectal Anastomosis (TICA) for Recurrent Ovarian Cancer: A Case Series and Description of the Technique.

Valerio Gallotta, Luca Palmieri, Francesco Santullo

|Oct 14, 2023
Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer.

Camilla Certelli, Silvio Andrea Russo, Luca Palmieri

Pageof 2

Frequent Collaborators

3 joint publications

Alessandro D Santin

3 joint publications

Victoria M Ettorre

2 joint publications

Riccardo Oliva

2 joint publications

Blair McNamara